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As the result of basic researches, several intravital ﬂuorophores have been determined so far in human colorectal tissue.
Autoﬂuorescence endoscopy (AFE) can detect slight alterations in their distribution and concentration during the colorectal
carcinogenesis process and, thus facilitate noninvasive screening colonoscopies without the need for ﬂuorescent substances or
staining reagents to be administered. While detecting faint autoﬂuorescence intensity by conventional ﬁberoptic endoscopy
remains challenging, the latest AFE system with high-resolution videoendoscope capabilities enables such detection by using a
false-color display algorithm. To this end, the diagnostic beneﬁts of AFE have been reported in several multicenter randomized
controlled studies of colorectal cancer (CRC) screening and diﬀerential diagnosis. CRC screening using the latest AFE technology
could, therefore, lead to future reductions in CRC mortality.
1.Introduction
Early detection and removal of colorectal adenomatous pol-
yps is essential in reducing the mortality rate of colorectal
cancer (CRC). Although there are several modalities for CRC
screening, colonoscopy is considered the most eﬀective pro-
cedure,allowing direct visualizationand on-site treatment of
theencounteredlesions.However,minuteorﬂat-typepolyps
are hard to detect even by conventional colonoscopy [1].
Narrow-band imaging (NBI) has been widely applied for the
diagnosis of colorectal neoplasm during colonoscopy [2–4].
However, recent prospective studies [5–7] failed to show the
eﬀectiveness of NBI in screening colonoscopies.
Autoﬂuorescence endoscopy (AFE) is now attracting at-
tention for its potential in improving diagnostic yields for
CRC. This technology was shown to detect slight alterations
inautoﬂuorescenceintensityinthecolorectalwallduringthe
carcinogenesis process [8, 9].
2. Principleof AFE
2.1. Fluorophores in Human Colorectal Tissue. When light is
focused onto a molecule, part of the light energy is reﬂected
or scattered, and the rest is absorbed. The energy status of
the molecule shifts from a ground state to a high-vibration
energy state—this is known as excitation. Excess energy is
emittedasthermalenergyorconsumedasvibrationalenergy
when the molecules revert to their ground state. However,
naturally ﬂuorescent molecules in tissue release such excess
energy as autoﬂuorescence, which can be detected and
measured.
Fluorophores determined so far in human colorectal tis-
sue include collagen, which forms the basement membrane
and the submucosal layer, NADH and FAD, which exist
mainly in gland cell mitochondria and lysosomal granules,
and porphyrin in the mitochondria of red blood cells and
gland cells.2 Gastroenterology Research and Practice
Autoﬂuorescence emission has been reported mainly
with respect to collagen distributed throughout the sub-
mucosal colorectal layer [8], with lower autoﬂuorescence
intensity also detected in neoplastic tissues. This reduced
intensity is attributed to the attenuated optical penetrability,
both for the excitation light and the autoﬂuorescence, caused
by the increased mucosal thickness and glandular density of
neoplasm [9].
2.2. Fluorescence Endoscopy. Several studies focusing on ﬂu-
orescence endoscopy combined with topical application of
ﬂuorescent substances such as porphyrin [10], tetracycline
[11], or ﬂuorescein [11] from the mid-20th century failed to
reveal a diagnostic value. Low tissue speciﬁcity and technol-
ogy deﬁcits resulted in a failure to detect faint ﬂuorescence
intensity. However, a recent prospective study by Mayinger
et al. [12] on the detection rate of colonic neoplastic
lesions by photodynamic diagnosis (PDD) using ﬂuores-
cence endoscopy (13902 PIKS; KARL STORZ, Tuttlingen,
Germany) with topical application of 5-aminolevulinic acid
(5-ALA), a precursor of porphyrin, and hexaminolevulinate
(HAL), a derivative of 5-ALA, found that both applied
ﬂuorophores have an aﬃnity for neoplastic tissues. In their
study, PDD detected 28% more neoplastic lesions than white
light endoscopy (WLE). Although PDD carries the inherent
risk of complications such as photosensitivity, the modality
has shown favorable diagnostic yields for detecting dysplasia
inpatientswithulcerativecolitis[13]andBarrett’sesophagus
[14].
2.3. Autoﬂuorescence Endoscopy. AFE detects intravital ﬂu-
orescent substances without administration of exogenous
ﬂuorescent agents. Firstly developed as an autoﬂuorescence
bronchoscope (light-induced ﬂuorescence endoscopy: LIFE,
Xillix Technologies, British Columbia, Canada) [15], the
technology was consequently applied to gastrointestinal
endoscopy (LIFE-GI) [16]. This system uses analog equip-
ment based on a ﬁberoptic endoscope and displays the ratio
of green and red autoﬂuorescence intensities as false color.
A study in 2001 by Haringsma et al. [17] revealed that AFE
based on this technology successfully visualized ﬂat lesions
10mm or larger in size, which were diﬃcult to detect by
WLE. However, this system had practical use problems in
a clinical setting, as it was equipped with a heavy camera
attached to the endoscope eyepiece [18].
The autoﬂuorescence imaging system from Olympus
(AFI system) is the latest AFE system and is equipped with
high-resolutionvideoendoscopecapabilities(CF-FH260AZI,
Figure 1). This system uses a switching function between
the WLE and AFE mode and the NBI mode, a zoom
function, and variable stiﬀness function. Figure 2 sets out
mechanistic details of the AFI system, in which false color
images are ultimately produced by allocating the ampliﬁed
autoﬂuorescence signal to the green (G) channel and the
reﬂected signal of green light to the red (R) and blue
(B) channels in the ratio of 1 to 0.5. The endoscopic im-
age is displayed in false color; areas with low and high
autoﬂuorescence intensity are shown in purple and green
Figure 1: High-resolution videoendoscope (CF-FH260AZI) used
in the autoﬂuorescence imaging system (Olympus Medical Systems
Corp, Tokyo, Japan).
tones, respectively. Figure 3(a) shows a WLE image of a 5-cm
lateral spreading tumor (granular type) in cecum, which is
displayed by AFE as purple, thus, providing a strong color
contrast with the surrounding normal mucosa shown in
green (Figure 3(b)).
Ac o m p a r a t i v es t u d y[ 20] between the LIFE-GI and
AFI systems for diﬀerentially diagnosing hyperplastic lesions
from colorectal adenomas revealed that sensitivity and spec-
iﬁcity were 87% and 71% for LIFE-GI and 89% and 81% for
AFI, respectively.
3. AFE inCRC Screening
Based on the advantage of AFE that colorectal lesions are
displayed in purple, which is like a “red ﬂag” in the sur-
rounding normal colorectal mucosa shown in green, several
randomized clinical trials have focused on the diagnostic
utility of AFE in screening by colonoscopy. In a randomized
controlled study using the AFI system [21], a modiﬁed back-
to-back colonoscopy using AFE and WLE was conducted for
167 patients in the right-sided colon by a single, experienced
colonoscopist. The patients were randomized to undergo the
ﬁrst colonoscopy with either AFE or WLE (group A: AFE-
WLE, group B: WLE-AFE). Among all detected polyps, the
number of neoplastic lesions detected by AFE and WLE
colonoscopy was 92 and 69, respectively. Among 66 neoplas-
tic lesions detected in group A, 47 (71%) were detected at
the ﬁrst AFE. In contrast, among 95 neoplastic lesions in
groupB,only50(53%)weredetectedattheﬁrstWLE,and45
(47%) lesions were detected by the subsequently performed
AFE.Thisindicatedthatsigniﬁcantlymoreneoplasticlesions
were missed by WLE compared with AFE (P = 0.02).Gastroenterology Research and Practice 3
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Figure 2: Schematic diagram of the AFI system [19]: white light emitted from a 300-W xenon lamp in the light source is separated with
a rotary ﬁlter into an excitation light with a wavelength range of 390 to 470nm and a green light of 540 to 560nm wavelength. These
fractionated lights radiate sequentially during the observation period. A barrier ﬁlter to remove reﬂected excitation light is set in front of
a monochrome charge-coupled device. Light of 500 to 630nm wavelength is selectively detected from both autoﬂuorescence and reﬂected
green light. A false color image is produced by allocating the detected and ampliﬁed autoﬂuorescence signal to the green (G) channel and
the reﬂected signal of green light to the red (R) and blue (B) channels in the ratio of 1 to 0.5.
(a) (b)
Figure 3: WLE image of 5-cm lateral spreading tumor (granular type) in cecum (a). With AFE, the lesion appears purple, which provides a
strong color contrast with the surrounding normal mucosa shown in green (b).
A back-to-back comparative study by Ramsoekh et al.
[22] analyzed the sensitivity of AFE and WLE for the
detection of colorectal adenomas in high-risk patients from
families with the Lynch syndrome or familial CRC. A total of
75 asymptomatic patients were examined with either WLE
followed by AFE or AFE followed by WLE. Back-to-back
colonoscopy was performed by two blinded endoscopists.
WLEidentiﬁedadenomasin28/41patientsandAFEin37/41
patients, representing a 32% diﬀerence in detection eﬃcacy.
In total, 95 adenomas were detected, 65 by WLE and 87
by AFE, indicating a signiﬁcantly higher sensitivity of AFE
compared with WLE (92% versus 68%; P = 0.001). In
addition, the additionally detected adenomas with AFE were
signiﬁcantly smaller than the adenomas detected by WLE
(mean 3.0mm versus 4.9mm; P<0.01).
Although early detection and removal of colorectal
adenomas is considered the most eﬀective way of preventing
colorectal cancer progression [19, 23], the impact of these
reported higher detection rates of adenomas by AFE on CRC
screening is still unclear due to the relatively small study
populations tested thus far. Moreover, whether AFE is useful
for detecting those depressed colorectal lesions with higher4 Gastroenterology Research and Practice
malignant potential is still unclear. These points should be
veriﬁed in future large-volume multicenter trials.
4. AFE in the DifferentialDiagnosis of
Colorectal Neoplasm
The false color range in AFE is determined based on the
calculation of balance between autoﬂuorescence intensity
and reﬂected green light intensity (Green/Red, G/R ratio),
and this balance could be aﬀected by thickness of the lesion,
degree of vascularity, and glandular density. We numerically
analyzed the color tone of colorectal lesions in AFE using
special color analysis software [24]. A total of 103 colorectal
lesions (22 nonneoplastic and 81 neoplastic lesions) were
analyzed, and the mean G/R ratio was signiﬁcantly higher
in nonneoplastic lesions (1.17 (95% CI, 1.10–1.24), n = 22)
than in neoplastic lesions (0.65 (95% CI, 0.63–0.68), n = 81)
(P<0.001). Under receiver operating characteristic analysis,
with a cut-oﬀ value of 1.01 for G/R ratio, it was shown that
AFE had a sensitivity and speciﬁcity of 98.8% and 86.4%,
respectively. This result indicated that the color tone in AFE
might directly visualize pathological features of colorectal
lesions, and its analysis may facilitate the automated optical
diagnosis of colorectal neoplastic lesions in the future.
5. Limitationsof the AFI System
Despite more advantages with the latest AFE technology, the
system still has some limitations that need to be overcome
for its full potential to be realised. The outside diameters of
the distal end and insertion tube are relatively thick (14.8
and 13.2mm, resp.) compared to those used in conventional
colonoscopy. This might limit maneuverability and, thus,
hinder polyp detection, especially of those lesions harbored
behind folds or ﬂexures. Use of a transparent hood (TH)
in AFE was shown to improve detection rates for colorectal
neoplasms [25]. In this study, 561 patients were allocated
among four groups: WLE alone, WLI without TH; WLI +
TH, WLE with TH; AFE alone, AFE without TH; AFI + TH,
AFE with TH. The neoplasm detection rate (95% conﬁdence
interval)intheAFI+THgroupwassigniﬁcantlyhigherthan
that in the WLE alone group (1.96 [1.50–2.43] versus 1.19
[0.93–1.44]; P = 0.023).
The AFI system has two other limitations—delayed dis-
play and low image resolution. In our system, both video-
frame rate and image resolution were reduced to create false-
colorimagesemployingveryfaintautoﬂuorescenceintensity.
In the future these factors should be overcome with system
reﬁnements so that CRC screening using this technology
becomes more practical.
6. Conclusion
In this paper, we reviewed several papers that focused on the
diagnostic value of AFE for CRC screening. We anticipate
that AFE may contribute to future reductions in CRC
mortality.
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